News

Lilly snags Peninsula non-opioid pain drug company for up to $1 billion
Eli Lilly acquires SiteOne Therapeutics for up to $1B, signaling potential uptick in Big Pharma deals and focus on non-opioid ...
BioPharma Dive7h
Lilly to buy pain drug developer SiteOne, challenging Vertex
The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.
Eli Lilly to buy privately held SiteOne in deal worth up to $1 billion
Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...
C&EN4d
Without these lipid shells, there would be no mRNA vaccines for COVID-19
During the late ’90s and through the first decade of the 2000s, Cullis, his colleagues at Inex Pharmaceuticals, and the Inex spin-off Protiva Biotherapeutics developed ionizable lipids that are ...
Stocks to Watch Today: ITC, Sun Pharma, IndusInd Bank, Honasa Consumer, MTAR Tech, Metro Brands, Power Mech, Bharat Electronics in focus on 23 May
Stocks like TD Power Systems, MITCON Consultancy & Engineering Services, Trent, Bharat Electronics, Nestle India, IndusInd ...